Among the molecular mechanisms that yield the overexpression and increased activity of FAK, gene amplification, mRNA upregulation through promotor hypomethylation (e.g., HCC, [161]), and splice variants have been characterized so far, with the latter yielding over-activated FAK isoforms, as exemplified by colorectal cancer [181]. Here, PTK2 is linked to hepatocellular carcinoma.